HIT Consultant
OCTOBER 13, 2022
What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,
Bill Of Health
DECEMBER 8, 2023
Attorney Gene Quinn offers the most dramatic interpretation, calling the Supreme Court’s embrace of full scope enablement in Amgen “a cataclysmic shift in the law of enablement,” not just for antibodies but for “the life sciences community and beyond.” Amgen’s significance has often been overstated. It was formally repealed in 2018.)
Health Advances
SEPTEMBER 15, 2020
Investors in Hong Kong who are closer to China can better understand the equity story of Chinese biotechnology companies. Following Hong Kong’s steps, Shanghai’s Science and Technology Innovation Market (STAR) changed its criteria to allow pre-revenue biotechs to list in May. explains Chen.
Expert insights. Personalized for you.
98 
Let's personalize your content